Global 3D Bioprinting Market – Future Growth Trend Highlights 2016-2022

The report on "Global 3D Bioprinting Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast " added by DecisionDatabases.com provides a comprehensive analysis including market value, forecasts, as well as a detailed competitive market analysis of major players of the 3D bioprinting market. 3D bioprinting is a commercial technology used for in vitro testing and other clinical fields related to the grafting of human tissue for efficient toxicity testing and drug discovery of personal care consumer products.It creates a 3-dimensional environment for human tissue to make the drug discovery method more efficient and reliable.
 
​​The recent technological advancements coupled with expanding healthcare infrastructure is expected to drive this market
over the current years. Additionally, rising number of geriatric population will further aid to the market growth for 3D bioprinting in the near future. The increasing prevalence of chronic diseases leading to tissue and organ transplants along with the increasing average life span of the human and restricted number of organ donors are also anticipated to fuel the market demand over the forecast period. However, shortage of skilled workforce and a high cost of this technology are major challenges, which can hinder market growth over the coming years.

Rising incorporation of information technology within the healthcare industry, in order to improve the overall system and increasing R&D expenditure, are likely to augment market growth in the coming years. Over the past few years, numerous research institutes and universities have completed various analyses to know the prospects of bio-printed implants for an efficient drug testing procedure.

The global 3D bioprinting market has been segmented on the basis of technology into magnetic levitation 3D bioprinting, inkjet-based 3D bioprinting, syringe based 3D bioprinting, laser based 3D bioprinting and others.  Magnetic levitation 3D bioprinting is a major technology segment and is expected to witness a significant growth over the forecast period owing to the growing demand for toxicity screening, organ failures and human cell regeneration due to its high recovery and efficient drug management. The 3D bioprinting market has been further segmented based on application into medical (tissue and organ generation, medical pills, and prosthetics & implants), dental, biosensors, personal product testing, bio inks and food & animal product. The medical segment is anticipated to dominate the market over the forecast period on account of the increasing demand for regeneration of tissues, organs, and prosthetics.

North America is a leading market and is projected to continue its dominance over the forecast period owing to the presence of a large number of geriatric population and increasing the prevalence of the chronic disorder in the region. Asia Pacific is anticipated to witness a substantial growth over the coming years due to their revolutionary presence in the development of healthcare IT and rising technological advancements.

The major industry players include 3D Systems, Organovo, CELLINK, Envision TEC, Materialise NV, Bio3D Technologies, Oceanz 3D printing & Additive Manufacturing, Solidscape, Stratasys Ltd., Voxeljet, Luxexcel Group BV, TeVido BioDevicesm, 3Dynamics Systems, Aspect Biosystems, BioBots and Cyfuse Biomedical.
 
In June 2016, Covestro has introduced a new range of filaments and powders to supply every common type of 3D printer and to drive the industry.for direct investment.

In June 2016, EnvisionTEC Launched cDLM , a 3D printing technology to introduce the first of its kind printing solution for direct casting models in a minute.
   
About-Us:
 
DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.
 
Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise and meaningful data at a lightning speed.

For more details:
DecisionDatabases.com                               
E-Mail:  [email protected]
Phone: +91 99 28 237112
Web: www.decisiondatabases.com/